首页> 外文期刊>Journal of drug delivery science and technology >Metal organic frameworks modified mesoporous silica nanoparticles (MSN): A nano-composite system to inhibit uncontrolled chemotherapeutic drug delivery from Bare-MSN
【24h】

Metal organic frameworks modified mesoporous silica nanoparticles (MSN): A nano-composite system to inhibit uncontrolled chemotherapeutic drug delivery from Bare-MSN

机译:金属有机框架改性介孔二氧化硅纳米粒子(MSN):纳米复合体系,以抑制来自裸照MSN的不受控制的化学治疗药物递送

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Mesoporous silica nanoparticles (MSN) are one of those compounds which have recently drawn attention in biomedical applications. But premature cargo leakage and uncontrolled release from bare MSN makes them unsuitable for drug delivery applications. Herein we report a new approach to modifying bare MSN to inhibit burst cargo release. The primary goal of this work was to combine metal organic framework (MOF) and MSN to form a nano-composite to build a hybrid drug delivery system to prevent premature drug release from bare-MSN. We first encapsulated Doxorubicin (DOX) inside MSN (MSN@DOX) and then used MSN@DOX to form composites through an in situ room temperature reaction in the aqueous medium with two biocompatible MOFs namely Fe-BTC and Zn-BTC. Two external triggering agents pH and liposome were used to conduct the drug release from MSN and the composite system. The pH-triggered release was conducted at three different pH 4, 6 and 7.4. MSN releases drug molecules within 2-3 h at all the pH whereas the composite system can control the release for more than four days. We also demonstrated that the drug release takes place for a significant period (4 days) when the newly developed DDS comes in contact with an artificial membrane such as liposomes. We evaluated the biological compatibility of these compounds in mammalian cell culture assay, and results show high biocompatibility of the DDS compared to earlier reports. The cytotoxicity study in HeLa and NIH3T3 cell line indicates that the composite systems are highly biocompatible and the cellular uptake studies of these composites using mouse embryonic fibroblast (NIH 3T3) cells and HeLa cells and DDS shows that the composite systems were successfully taken by cells without any morphological damages. MSN@DOX and MOF/MSN@DOX composites were characterized by transmission electron microscopy (TEM), bright field, confocal imaging, scanning electron microscopy (SEM), dynamic light scattering (DLS), X-ray powder diffraction (PXRD), IR-spectroscopy and thermogravimetric analysis (TGA). The results indicate that the newly prepared MOF/MSN@DOX DDS is superior to bare MSN based DDS. Overall, the present study highlights a new approach for controlled delivery of DOX from a MOF modified MSN, and hope that it will help to the further development of DDS based on composites materials shortly.
机译:中孔二氧化硅纳米粒子(MSN)是最近在生物医学应用中引起关注的那些化合物之一。但是从裸机泄漏和不受控制的MSN不受控制的泄漏使它们不适合药物递送应用。在此,我们报告了一种改进裸照MSN以抑制爆发货物释放的新方法。这项工作的主要目标是将金属有机框架(MOF)和MSN结合形成纳米复合材料以构建杂种药物输送系统,以防止裸照MSN的过早药物释放。我们首先封装MSN内部(MSN @ DOX)内的多柔比星(DOX),然后使用MSN @ DOX通过在水性介质中使用两种生物相容性MOF和Zn-BTC在水性介质中形成复合材料。两个外部触发剂pH和脂质体用于从MSN和复合体系中进行药物释放。 pH触发的释放在三种不同pH 4,6和7.4中进行。 MSN在所有pH下释放2-3小时内的药物分子,而复合系统可以控制释放超过4天。我们还表明,当新开发的DDS与人工膜如脂质体接触时,药物释放发生了很大的时间(4天)。我们评估了这些化合物在哺乳动物细胞培养测定中的生物相容性,结果显示了与早期报告相比DDS的高生物相容性。 HeLa和NiH3T3细胞系中的细胞毒性研究表明,复合系统是高度的生物相容性,并且使用小鼠胚胎成纤维细胞(NIH 3T3)细胞和HELA细胞和DDS的这些复合材料的蜂窝摄取研究表明,复合体系成功通过细胞捕获任何形态损害。 MSN @ DOX和MOF / MSN @ Dox复合材料的特点是透射电子显微镜(TEM),明亮场,共聚焦成像,扫描电子显微镜(SEM),动态光散射(DLS),X射线粉末衍射(PXRD),IR - 光谱学和热重分析(TGA)。结果表明,新建的MOF / MSN @ DOX DDS优于基于MSN的DDS。总体而言,本研究强调了一种新方法,用于从MOF修改的MSN控制DOX的交付,并希望它将有助于基于复合材料的DDS进一步发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号